First patent awarded to a micronutrient preparation for the support of endometriosis
Endometriosis is a chronic disease that affects about 10% of all women of childbearing age. In endometriosis, tissue strongly resembling uterine lining grows outside the inner uterine cavity. This tissue reacts to the female menstrual cycle like uterine mucosa itself, i.e. it builds up during the cycle, breaks down at the time of menstruation, but cannot leave the body. This leads to inflammation, which can be felt as intense pain (not only during menstruation). Unfortunately, diagnosis often is difficult and may take a long time. It is not uncommon that endometriosis is only diagnosed when a patient with an unfulfilled desire to have a child presents at a fertility clinic.
Common cause of subfertility
This is because endometriosis not only affects the well-being of women, but can also impair natural conception. For instance, when endometriomas are found in the area of the fallopian tubes, they may constitute a mechanical obstacle to a natural conception. Very often, endometriosis-associated inflammation and oxidative stress may impair healthy fertility by lowering oocyte quality.
Unfortunately, treatments for the disease are often quite invasive and include both surgical procedures and strong drugs. However, an influence of lifestyle and diet has also been established and many women are highly interested to use this knowledge to their advantage. In particular, stress-reduction, minding individual intolerances and an anti-inflammatory diet present helpful for many women.
First patent granted for orthomolecular treatment
Nevertheless, so far there has been nothing available for endometriosis patients in the otherwise comprehensive micronutrient market. This often made orthomolecular treatment unnecessarily complicated and expensive. It is all the more pleasing that the first patent has finally been granted for a product that supports endometriosis patients gently and naturally from within with the help of a specific nutrient combination (Fertilovit® F Endo). It is particularly interesting for women wishing to have children that, according to initial studies, the ingredients can also contribute to the protection of sensitive oocytes from damage caused by increased inflammation and oxidative stress due to endometriosis. The patent holder is Gonadosan Distribution GmbH, based in Bregenz, Austria. The product manager, Doctor Birgit Wogatzky, explains: "As a company, we originate from the field of fertility medicine and have specialized in supportive micronutrient therapy of fertility patients since our inception."
With the Fertilovit® product line (www.fertilovit.com), the company already offers a selection of special micronutrient preparations for fertility patients with a wide range of medical histories. However, since many patients who present with unfulfilled desire to have children suffer from endometriosis, it was a concern to finally be able to offer these patients targeted support as well.
Innovative combination product supports and protects
New research data enabled the development of the combination product Fertilovit® F Endo (https://shop.fertilovit.com/fertilovit-products/en-fertilovit-f-endo-45.aspx), which provides patients not only with the protective folic acid, which is important for women wishing to have children, but also with special antioxidants and anti-inflammatory nutrients. Study data show that in many cases this can be an extremely helpful and at the same time gentle support when planning for pregnancy. A pleasant side effect for many patients is that it is not uncommon to see an improvement in the pain situation. By the way, the patented combination is available both in pharmacies as well as on the Internet (https://shop.fertilovit.com/fertilovit-products/en-fertilovit-f-endo-45.aspx).
Gonadosan Distribution GmbH
Tel. +43 5574 54195
Gonadosan - this is the name of an innovative company with branches in Switzerland and Austria.
An interdisciplinary team is continuously working on the development and research of new orthomolecular concepts. The know-how and extraordinary commitment of this team contribute significantly to the success of the company and its products.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release First patent awarded to a micronutrient preparation for the support of endometriosis here
News-ID: 2028075 • Views: 196
More Releases from Gonadosan Distribution GmbH
Birth control pills and nutrient deficiencies - why it's so important to close s â€¦
Many women regularly suffer from headache, mood swings, tiredness, impaired immune function and loss of libido. Very often it is hard to identify any underlying medical reason for these issues. Interestingly, something many of these women have in common: they use hormonal oral contraceptives, commonly referred to as birth control pills. In the so called ,,pill-report", which was published by the University of Bremen, Germany, in 2015, scientists assessed use of
More Releases for Endo
Flame Resistant Clothing Market Outlook to 2023 â€“ Body Products, Changzhou Hea â€¦
Sept 2018, New York USA (News)- Researchreportsinc.com adds "Global Flame Resistant Clothing Market: Size, Trends & Forecasts (2018-2023)" report to its research store. This research provides market analysis of size, share, trends, value, volume, country coverage, market dynamics, and competitive landscape. Request for FREE Sample of Global Flame Resistant Clothing Market 2018 Research Report @ https://www.researchreportsinc.com/sample-request?id=196756 The global market size of Flame Resistant Clothing Market is $XX million in 2017 with
Worldwide Transdermal Drug Delivery Systems Industry 2018 | Top Players- Endo In â€¦
The Global TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics,
Global Perphenazines Market 2018 - Teva, Sandoz, Endo, Mylan
Apex Market Reports, recently published a detailed market research study focused on the â€śPerphenazines Marketâ€ť across the global, regional and country level. The report provides 360Â° analysis of â€śPerphenazines Marketâ€ť from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Perphenazines on the basis of
Global Polypectomy Snares Market 2018 - Blue Endo, Carmonja, EMED, Endo-Flex
The statistical surveying information incorporated into the Polypectomy Snares report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Polypectomy Snares based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Polypectomy Snares advertise covering key factors, for example, drivers and
Polypectomy Snares Market - Blue Endo (USA), Changzhou Health Microport Medical â€¦
Global Polypectomy Snares Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Polypectomy Snares Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players: Blue Endo (USA) Changzhou Health Microport Medical Devices (China) EMED (Poland) Endo-Flex (Germany) Endo-Therapeutics (USA) EndoChoice (USA) ENDOMED (Germany) Healthcare Medical Changzhou (China) Jiangsu Kangjin Medical Instruments (China) Medi-Globe (Germany) Mednova Medical Technology (China) Ovesco Endoscopy (Germany) Pauldrach Medical (Germany) Sejong
Lidocaine Patches Market 2017 - Acorda Therapeutics, Endo International, GlaxoSm â€¦
Apex Research, recently published a detailed market research study focused on the "Lidocaine Patches Market" across the global, regional and country level. The report provides 360Â° analysis of "Lidocaine Patches Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lidocaine Patches industry, and estimates the future trend of Lidocaine Patches market on